Stay updated on Ipilimumab Nivolumab in Mucosal Melanoma Clinical Trial
Sign up to get notified when there's something new on the Ipilimumab Nivolumab in Mucosal Melanoma Clinical Trial page.

Latest updates to the Ipilimumab Nivolumab in Mucosal Melanoma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check31 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3. No study content or user-facing information appears to be altered.SummaryDifference0.1%

- Check52 days agoChange DetectedRevision: v3.4.2 is displayed, replacing v3.4.1; no study content, endpoints, or navigation were altered.SummaryDifference0.1%

- Check59 days agoChange DetectedThe page now displays Revision: v3.4.1 instead of v3.4.0. All study content, links, and instructions appear unchanged.SummaryDifference0.1%

- Check82 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check104 days agoChange DetectedAdded a consolidated Locations section listing Florida, Iowa, Minnesota, Nebraska, Oregon, and Pennsylvania. Updated the revision to v3.3.3 and removed the prior separate location sections (Florida Locations, Iowa Locations, Minnesota Locations, Nebraska Locations, Oregon Locations, Pennsylvania Locations) along with the HHS Vulnerability Disclosure link.SummaryDifference0.7%

Stay in the know with updates to Ipilimumab Nivolumab in Mucosal Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipilimumab Nivolumab in Mucosal Melanoma Clinical Trial page.